Startups
Thryv Therapeutics
Develops selective SGK1 inhibitors for inherited heart-rhythm disorders, heart failure and neurodegenerative disease. Its lead oral drug candidate, THRV-1268, is in clinical development for Long QT Syndrome. A separate licensed chemistry program is being developed for brain-penetrant compounds targeting Parkinson’s disease, Alzheimer’s disease and related disorders. Founded as LQT Therapeutics, the company adopted the Thryv name in 2022.
Founded 2019
Team
Aidan McNeilSenior Vice President, Administration & Associate General Counsel |
Alexandre BrkovicVice President, Clinical Research |
Alicia SchiaviAssociate Director, Clinical Operations |
Amy RudolphBoard Director |
Amy SehnertChief Medical Officer |
Anthony RosenzweigScientific Co-Founder |
Arthur A.M. WildeScientific Advisory Board Member |
Ashley Prasse MillerVice President, Clinical Operations |
Brittany HagenManager, Communications |
Curtis McGrathVice President, Finance |
Daniel HétuBoard Director |
David MilanScientific Co-Founder |
Debra OdinkPresident & Chief Development Officer |
Delphine LabitDirector, Research |
Dinesh SrinivasanVice President, Strategic Portfolio Management |
Dominic AbramsScientific Advisory Board Member |
Frédéric Lemaître AugerBoard Observer |
Jean-François PariseauBoard Director |
Jennifer L. StrandeExecutive Director, Clinical Development |
Julie VattéResearch Scientist |
Justine KellerDirector, Finance |
Kayluz Frias BoliganResearch Scientist |
Marc VidalVice President, Chemistry |
Marc-Olivier SirardBoard Director |
Marco PerezScientific Advisory Board Member |
Maroua KhalifaAssociate Director, Pharmaceutical Development |
Matt KilleenChief Business Officer |
Maxime DaigleBoard Observer |
Melissa KoomeyBoard Director |
Michael J AckermanScientific Advisory Board Member |
Paul DorianScientific Advisory Board Member |
 Paul F. TruexChairman Of The Board & Chief Executive Officer |
Philip SagerScientific Advisory Board Member |
Philippe BeauclairPostdoctoral Researcher, Chemistry |
Ravi ShahKey Advisor, Heart Failure |
Robert BoothBoard Director |
Roger DamleScientific Advisory Board Member |
Sabindra PradhanangaAssociate Director, Non-Clinical Development |
Saumya DasChief Scientific Advisor and Scientific Co-Founder |
Scott WeinerBoard Observer |
Shannon HewgillResearch Associate |
Stanley NattelScientific Advisory Board Member |
Youssef BennaniBoard Observer |